bcrcweb@firdi.org.tw

(03)5223191

300193 No. 331, Food Road, East District, Hsinchu City

Logo
FIRDI BCRC

News

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2024 to 31st of December, 2024. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2023 to 31st of December, 2023. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2022 to 31st of December, 2022. Information regarding patented biological materials deposition services, please refer to the following link:https://patent.bcrc.firdi.org.tw/。
111年公告.pdf (chinese only)

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2021 to 31st of December, 2021. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
110年公告.pdf (chinese only)

“Regulations for the Deposit of Biological Material for Patent Application” was not so reader friendly for first-time users, thus “Guideline to the deposit of biological materials for patent purposes” was issued. This guideline was revised and updated in 2020 and are now available online in Chinese only, hoping to clarify the deposition process and made it more user-friendly for depositors. Detailed contents please refer to the “Guideline to the deposit of biological materials for patent purposes” page. 詳細內容請參考<專利生物材料寄存說明手冊>(chinese only)網頁

”Operational Directions Governing the Mutual Cooperation between Taiwan Intellectual Property Office and Korea Patent Office in the Field of Deposit of Biological Materials for the Purposes of Patent Procedure” was promulgated on 1st of September, 2020; entered into force on 1st of September, 2020.
1090901臺韓生物材料寄存作業要點總說明及逐點說明.pdf(chinese only)
1090901臺韓生物材料寄存作業要點.pdf(chinese only)

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2020 to 31st of December, 2020. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
109年公告.pdf(chinese only)

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2019 to 31st of December, 2019. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
108年公告.pdf(chinese only)

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2018 to 31st of December, 2018. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
107年公告.pdf

“Operational Directions Governing the Mutual Cooperation between Taiwan Intellectual Property Office and United Kingdom Intellectual Property Office in the Field of Deposit of Biological Material for the Purposes of Patent Procedure”were promulgated on December 4, 2017; entered into force retroactively on December 1, 2017. English site: http://rootlaw.com.tw/en/LawArticle.aspx?LawID=A040100091007600-1061204
(檢附:臺英專利程序上生物材料寄存相互合作作業要點)(chinese only) (檢附:臺英專利程序上生物材料寄存相互合作Q&A)(chinese only)

Regarding Paragraph 1 of Article 9, Regulations for the Deposit of Biological Material for Patent Application, after performing the viability test, the biological material cannot be proven to be viable, including other microorganisms contaminations resulted in biological materials cannot be furnished in the future, (for example: animal cell lines contaminated by mycoplasma). As a consequence, animal cell lines viability tests shall include mycoplasma test. Viability statement shall state “not viable” if mycoplasma test results showed positive for contamination.
智惠字第10612206980號.pdf(chinese only)

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2017 to 31st of December, 2017. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
106年公告.pdf(chinese only)

If biological materials were within the definition of Paragraph 1 Article 15, Plant Protection and Quarantine Act, legal deposit or exhibition, sharing is feasible with the approval of the central competent authority. Depositor shall give extra time and file application earlier, which may reduce the possibility of not obtaining the import permits, completing the deposition, or obtaining the certificate of deposit for submission to the Intellectual Property Office, MOEA
植物防疫檢疫法103.pdf(chinese only)

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2016 to 31st of December, 2016. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
105年公告.pdf(chinese only)

Amendments of Article 11 and Article 25 in Regulations for the Deposit of Biological Material for Patent Application were promulgated on 4th of June, 2015; entered into force retroactively on 18th of June, 2015.
(檢附:修正條文含附表)(chinese only)

”Operational Directions Governing the Mutual Cooperation between Taiwan Intellectual Property Office and Japan Patent Office in the Field of Deposit of Biological Materials for the Purposes of Patent Procedure” was promulgated on 1st of June, 2015; entered into force on 18th of June, 2015.
(檢附: 臺日專利程序上生物材料寄存相互合作作業要點含附表)(chinese only)

When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2015 to 31st of December, 2015. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
104年公告.pdf(chinese only)

Patent deposit and other deposit policy announcement document in PDF format available online (Chinese Only).
專利寄存與其他寄存之適用宣導.pdf(chinese only)

Guidelines for Patent Deposit online version published. (Chinese only)。
專利寄存手冊網路版(chinese only)


When filing a patent application for invention involving a biological material or utilization of a biological material, the applicant shall make a deposit of the biological material with a domestic depository designated by the Intellectual Property Office, MOEA. The deposit of biological material services may be filed to the depository institution (hereinafter referred to as “the Depository”, here as FIRDI) ,, designated by the Intellectual Property Office, MOEA, from 1st of January , 2013 to 31st of December, 2013. Information regarding patented biological materials deposition services, please refer to the following link: https://patent.bcrc.firdi.org.tw/。
102年公告.pdf(chinese only)

Regulations for the Deposit of Biological Material for Patent Application was revised and promulgated on 4th of December, 2012; entered into force on 1st of January, 2013. The key point of this amendment is Article 24 that the certificate of deposit shall be submit the viability test report within the time period set by the Specific Patent Agency. FIRDI will only issue the certificate of deposit after completion of the viability test. For normal cases, it would take in average 10 working days for FIRDI to complete the viability test and issue the certificate of deposit. As for cases that the relevant information of the biological material or its culture medium were needed to be provided by the depositor, the duration of the case may be prolonged. Depositors shall apply as soon as possible to prevent exceeding the statutory time for patent application. If there is any enquiries, please contact us on +886-3-522-3191 ext 513, or email us on bcrcweb@firdi.org.tw
寄存辦法之修正內容請參閱經濟部智慧財產局之公告(https://www.tipo.gov.tw/ct.asp?xItem=318875&ctNode=7452&mp=1)。更新日期：101年12月04日
食品所備有｢專利生物材料寄存說明手冊｣，歡迎索取。(https://www.tipo.gov.tw/ct.asp?xItem=285889&ctNode=6677&mp=1)。更新日期：101年12月28日
如有任何問題，請利用電話(03)5223191 分機513，或電子郵件信箱bcrcweb@firdi.org.tw洽詢。